Search Results - "Schuster, Tilman"

Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS) by Titievsky, Lina, Schuster, Tilman, Wang, Ronnie, Younus, Muhammad, Palladino, Andrew, Quazi, Kabir, Wajnrajch, Michael P, Hernandez, Betina, Becker, Pamela S, Weinreb, Neal J, Chambers, Christina, Mansfield, Roy, Taylor, Louise, Tseng, Li-Jung, Kaplan, Paige

“…Limited real-world data from routine clinical care are available on the safety and effectiveness of treatment with taliglucerase alfa in patients with Gaucher…”
Get full text

Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A by Schuster, Tilman, Mühlstein, Astrid, Yaghootfam, Claudia, Maksimenko, Olga, Shipulo, Elena, Gelperina, Svetlana, Kreuter, Jörg, Gieselmann, Volkmar, Matzner, Ulrich

“…The lysosomal storage disorder (LSD) metachromatic leukodystrophy (MLD) is caused by a deficiency of the soluble, lysosomal hydrolase arylsulfatase A (ASA)…”
Get full text

Evaluation of an oral small-molecule glucagon-like peptide-1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose-ranging, phase 2, randomized, placebo-controlled study by Amin, Neeta B, Frederich, Robert, Tsamandouras, Nikolaos, Haggag, Amina Z, Schuster, Tilman, Zmuda, Witold, Palmer, Alexandra, Vasas, Szilard, Buckley, Gina, Smith, Timothy R, DuBrava, Sarah J, Zhu, Qi, Johnson, Margot

“…The aim was to investigate the effects of lotiglipron, a once-daily, oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, in participants with…”
Get full text

Baseline characteristics of patients with Gaucher disease enrolled in the taliglucerase alfa surveillance (TALIAS) registry by Titievsky, Lina, Schuster, Tilman, Wang, Rong, Becker, Pamela, Weinreb, Neal, Kaplan, Paige, Chambers, Christina, Quazi, Kabir, Hernandez, Betina, Wajnrajch, Michael P.

Get full text